Comprehensive genomic profiles of small cell lung cancer

Julie George, Jing Lim, Se Jin Jang, +92

Nature

Cancer GenomicsBronchial NeoplasmComprehensive Genomic ProfilesMolecular DiagnosticsRadiation Oncology +1

Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

Marcin Imieliński, Alice H. Berger, Peter S. Hammerman, +42

Cell

Tumor BiologyEngineeringTumor HeterogeneityMedicineNext-generation Sequencing +10

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

Martin Peifer, Lynnette Fernandez‐Cuesta, Martin L. Sos, +89

Nature Genetics

EngineeringSomatic VariantTumor HeterogeneityMedicineGenetics +8

Frequent and Focal <i>FGFR1</i> Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

Jonathan M. Weiss, Martin L. Sos, Danila Seidel, +59

Science Translational Medicine

Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

Peter S. Hammerman, Martin L. Sos, Alex H. Ramos, +53

Cancer Discovery

Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

Julie George, Vonn Walter, Martin Peifer, +59

Nature Communications

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

Lynnette Fernandez‐Cuesta, Martin Peifer, Xin Lü, +43

Nature Communications

ChromatinFrequent MutationsGeneticsBronchial NeoplasmPulmonary Blastoma +5

<i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma

Lynnette Fernandez‐Cuesta, Dennis Plenker, Hirotaka Osada, +48

Cancer Discovery

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen, +35

Nature Medicine

MedicineCancer BiologyCo-targeting Igf-1rCancer TreatmentRadiation Oncology +5

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz‐Cuaran, Matthias Scheffler, Dennis Plenker, +33

Clinical Cancer Research